According to the "2019-2022 China Medical Device Market Big Data and Benchmarking Enterprise Operation Monitoring Report" released by AiMedia Consulting, China's medical device market size has been growing steadily in the past five years, and there are mainly the following five favorable factors:

I.Policy dividend: the areas encouraged by the policy have a large market space, high technological barriers, and a good competition pattern, and the relevant leading enterprises have a broad development prospects.

Two, domestic enterprises to catch up: local enterprises began to pay attention to their own R & D and innovation capabilities, with the increase in the scale and number of mergers and acquisitions and restructuring of local enterprises will enable local enterprises to improve their product lines, optimize the product mix, and become more and more powerful.

Three, the domestic product sales channels comprehensive: domestic enterprise products basically cover all provincial and municipal level and some county hospitals, to take the direct sales strategy, and created a closed-loop sales channels and a variety of sales strategies.

Fourth, the industry's rapid development: in vitro diagnostics, cardiovascular interventional devices, medical imaging, orthopedic implants is the largest segment, while molecular diagnostics, minimally invasive surgical instruments, biomaterials, bio-implantation technology, drug delivery is the hot spot of technological development.

Domestic products have a price advantage: cardiovascular stents, for example, in 2008, the unit price of imported drug stents between 1.59 ~ 1, 930,000 yuan, while the equivalent WisdomLink's domestic stents between 1.08 ~ 1.10 million yuan, the domestic products have a greater price advantage.